Literatur zu Kapitel 3.8: Klinische Formen des Melanoms

• Adler MJ, White CR Jr.
  Amelanotic malignant melanoma.
  Semin Cutan Med Surg 1997;16:122-130.




• Barnetson RS, Halliday GM.
  Regression in skin tumours: a common phenomenon.
  Australas J Dermatol 1997;38 Suppl 1:63-65.




• Binder M et al.
  Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists.
  J Am Acad Dermatol 1997;36:197-202.




• Blessing K, Evans AT, al-Nafussi A.
  Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases.
  Histopathology 1993;23:453-458.




• Dummer R et al.
  Melanozytäre Nävi und kutanes Melanom.
  Schweiz Med Forum 2002;10:224-230.




• Garbe C et al.
  Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
  J Invest Dermatol 1994;102:700-705.




• Garbe C et al.
  The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin.
  Hautarzt 1995;46:683-692.




• Gibson LE, Goellner JR
  Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination.
  Mayo Clin Proc 1988;63:777-782.




• Helmke BM, Otto HF.
  Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal.
  Pathologe 2004;25:171-177.




• Hofbauer GF et al.
  Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
  J Cutan Pathol 1998;25:204-209.




• Hurst EA, Harbour JW, Cornelius LA.
  Ocular melanoma: a review and the relationship to cutaneous melanoma.
  Arch Dermatol 2003;139:1067-1073.




• Inskip PD, Devesa SS, Fraumeni JF Jr.
  Trends in the incidence of ocular melanoma in the United States, 1974-1998.
  Cancer Causes Control 2003;14:251-257.




• Koch SE, Lange JR.
  Amelanotic melanoma: the great masquerader.
  J Am Acad Dermatol 2000;42:731-734.




• Kuehnl-Petzoldt C, Berger H, Wiebelt H.
  Verrucous-keratotic variations of malignant melanoma: a clinicopathological study.
  Am J Dermatopathol 1982;4:403-410.




• Prasad ML et al.
  Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors.
  Cancer 2004;100:1657-1664.




• Schuchter L et al.
  A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.
  Ann Intern Med 1996;125:369-375.




• Steiner A et al.
  Verrucous malignant melanoma.
  Arch Dermatol 1988;124:1534-1537.